MINDCURE Achieves Key Development Milestone for Novel Ibogaine Program Post published:March 2, 2022 Post category:Press Release
Red Light Holland Reports Fiscal Third Quarter Results Post published:March 1, 2022 Post category:Press Release
Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study Post published:March 1, 2022 Post category:Press Release
Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders Post published:February 28, 2022 Post category:Press Release
Psychedelic Bulletin: Following the Money – How Much do Psychedelics Companies Spend on R&D? Post published:February 28, 2022 Post category:Psychedelic Bulletin
HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research Post published:February 24, 2022 Post category:Press Release
Entheon Biomedical Announces EBIQ-101 First-Patient Dose Post published:February 24, 2022 Post category:Press Release
Lobe Sciences Ltd. Strengthens Its Balance Sheet Post published:February 24, 2022 Post category:Press Release
COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights Post published:February 24, 2022 Post category:Press Release
MindMed Converts Multiple Voting Shares to Subordinate Voting Shares Post published:February 23, 2022 Post category:Press Release